|
ME03766B
(en)
|
|
CERTAIN AMINO-PYRIMIDINES, THEIR COMPOSITIONS, AND METHODS OF THEIR USE
|
|
EP2675471A4
(en)
|
|
Hsa-related compositions and methods of use
|
|
SG10202009963PA
(en)
|
|
Melanin modification compositions and methods of use
|
|
SG11201406948PA
(en)
|
|
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
|
PL3199024T3
(en)
|
|
Use of the cyclodextrin composition and appropriate methods
|
|
PL2734049T3
(en)
|
|
PROBIOTIC COMPOSITIONS AND METHODS
|
|
PL3812360T3
(en)
|
|
Monochlorotrifluoropropene compounds and compositions and methods of their use
|
|
EP2678018A4
(en)
|
|
Combination of kanase inhibitors and uses thereof
|
|
BR112014010450A2
(en)
|
|
composition and method
|
|
IL225227A0
(en)
|
|
Fulvestrant compositions and methods of use
|
|
BR112014006291A2
(en)
|
|
composition and use of composition
|
|
FI20096058A0
(en)
|
|
Compositions and related methods and uses
|
|
FI20135146L
(en)
|
|
PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT
|
|
BR112014014213A2
(en)
|
|
hemostatic agents and method of use
|
|
PL2830654T3
(en)
|
|
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATION
|
|
PL3400958T3
(en)
|
|
COMPOSITIONS AND METHODS OF TREATMENT OF CELIAKII
|
|
DK2661274T3
(en)
|
|
COMPOSITIONS AND METHODS OF ALOEPOLYSACCHARIDES
|
|
IL232115A0
(en)
|
|
Pharmaceutical compositions comprising dgla and /or 15-hetre and methods of use thereof
|
|
BR112012029669A2
(en)
|
|
composition and method
|
|
BR112013014915A2
(en)
|
|
curative composition and treatment methods
|
|
ZA201302952B
(en)
|
|
Fungicidal compositions and methods of use
|
|
BR112014010860A2
(en)
|
|
composition and method
|
|
BR112013008812A2
(en)
|
|
composition and method
|
|
BR112014007779A2
(en)
|
|
method and composition
|
|
BR112014009501A2
(en)
|
|
organogel and cosmetic composition
|